Literature DB >> 15809719

Involvement of matrix metalloproteinase-7 in invasion-metastasis through induction of cell dissociation in pancreatic cancer.

Xiaodong Tan1, Hiroshi Egami, Shinji Ishikawa, Hideki Sugita, Hidenobu Kamohara, Masahide Nakagawa, Fumiaki Nozawa, Michio Abe, Michio Ogawa.   

Abstract

Epidermal growth factor receptor (EGFR) mediated mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway was isolated as invasion-metastasis related factor in pancreatic cancer in our previous studies. Matrix metalloproteinase-7 (MMP-7) and tight junction (TJ) proteins are indicated to be involved in cancer invasion-metastasis. To clarify the underlying mechanism of involvement of MMP-7 in cancer invasion, western blotting, invasion assay and immunohistochemistry were performed in dissociated (PC-1.0 and AsPC-1) and non-dissociated (PC-1 and Capan-2) pancreatic cancer cells, as well as pancreatic cancer tissues. Intracellular MMP-7 protein presented as pre-proenzyme and its expression was decreased by AG1478 (EGFR inhibitor) or U0126 (MEK inhibitor) treatment in pancreatic cancer cells. Activated MMP-7 protein was only detected in the medium of PC-1.0 and AsPC-1 cells, but not detected in the medium of PC-1 and Capan-2 cells. Moreover, MMP-7 treatment significant induced the dissociation of cell colonies in PC-1 and Capan-2 cells. Synchronously, TJ structure was apparently disrupted and translocation of TJ proteins to cytoplasm or extracellular medium was induced in PC-1 and Capan-2 cells. Furthermore, MMP-7 treatment markedly increased the in vitro invasion of PC-1 and Capan-2 cells. In addition, MMP-7 expression at the invasive front was obviously stronger than that at the center of pancreatic cancer tissues. Activation of MMP-7 protein is closely involved in disruption of TJ structure and consequent induction of cell dissociation as well as invasion in pancreatic cancer. EGFR mediated MEK/ERK signaling pathway is implied to be involved in regulation of MMP-7 expression in pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809719

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  Association of Matrix Metalloproteinase 7 Expression With Pathologic Response After Neoadjuvant Treatment in Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Sami Shoucair; Jianan Chen; James R Martinson; Joseph R Habib; Benedict Kinny-Köster; Ning Pu; A Floortje van Oosten; Ammar A Javed; Eun Ji Shin; Syed Z Ali; Kelly J Lafaro; Christopher L Wolfgang; Jin He; Jun Yu
Journal:  JAMA Surg       Date:  2022-07-13       Impact factor: 16.681

2.  KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.

Authors:  Faraz Bishehsari; Lijuan Zhang; Usman Barlass; Nailliw Z Preite; Sanja Turturro; Matthew S Najor; Brandon B Shetuni; Janet P Zayas; Mahboobeh Mahdavinia; Abde M Abukhdeir; Ali Keshavarzian
Journal:  Int J Cancer       Date:  2018-08-09       Impact factor: 7.396

3.  Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis.

Authors:  Hui Liu; Jing Huang; Benquan Wu; Yuqi Zhou; Jiaxin Zhu; Tiantuo Zhang
Journal:  Med Oncol       Date:  2008-03-14       Impact factor: 3.064

4.  Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro.

Authors:  Chen Huang; Guang Yang; Tao Jiang; Kejian Huang; Jun Cao; Zhengjun Qiu
Journal:  J Exp Clin Cancer Res       Date:  2010-05-19

5.  Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion.

Authors:  Guang Yang; Chen Huang; Jun Cao; Ke-Jian Huang; Tao Jiang; Zheng-Jun Qiu
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

6.  Differential expression profiles of microRNAs in highly and weakly invasive/metastatic pancreatic cancer cells.

Authors:  Xiaodong Tan; Lei Zhou; Huaitao Wang; Yifan Yang; Yang Sun; Zhaoping Wang; Xiaobo Zhang; Feng Gao; Hansi Li
Journal:  Oncol Lett       Date:  2018-08-23       Impact factor: 2.967

7.  STAT3 knockdown reduces pancreatic cancer cell invasiveness and matrix metalloproteinase-7 expression in nude mice.

Authors:  Hai dong Li; Chen Huang; Ke jian Huang; Wei dong Wu; Tao Jiang; Jun Cao; Zhen zhong Feng; Zheng jun Qiu
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

8.  Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.

Authors:  Teijiro Hirashita; Yukio Iwashita; Masayuki Ohta; Yoko Komori; Hidetoshi Eguchi; Kazuhiro Yada; Seigo Kitano
Journal:  J Gastrointest Surg       Date:  2012-01-13       Impact factor: 3.452

9.  Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.

Authors:  Shih-Hsun Chen; Wei-Chien Hung; Pu Wang; Colin Paul; Konstantinos Konstantopoulos
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.

Authors:  Linh Nguyen; Theodora Fifis; Caterina Malcontenti-Wilson; Lie Sam Chan; Patricia Nunes Luiza Costa; Mehrdad Nikfarjam; Vijayaragavan Muralidharan; Christopher Christophi
Journal:  BMC Cancer       Date:  2012-11-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.